Loading...
United Health Products, Inc.
UEEC•PNK
Healthcare
Medical - Instruments & Supplies
$0.08
$-0.01(-8.57%)
United Health Products, Inc. (UEEC) Financial Performance & Income Statement Overview
Review United Health Products, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
17.27%
↑ 17.27%
Net Income Growth
23.69%
↑ 23.69%
Operating Cash Flow Growth
45.71%
↑ 45.71%
Operating Margin
-59002.96%
↓ 59002.96%
Gross Margin
-23.91%
↓ 23.91%
Net Profit Margin
-59190.43%
↓ 59190.43%
ROE
130.95%
↑ 130.95%
ROIC
180.50%
↑ 180.50%
United Health Products, Inc. (UEEC) Income Statement & Financial Overview
Review United Health Products, Inc.'s (UEEC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $1245.00 | $1358.00 |
| Gross Profit | $0.00 | $0.00 | -$1245.00 | -$1358.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $108779.00 | $65885.00 | $65720.00 | $115551.00 |
| SG&A Expenses | $676619.00 | $326018.00 | $339457.00 | $308185.00 |
| Operating Expenses | $785398.00 | $391903.00 | $405177.00 | $423736.00 |
| Total Costs & Expenses | $785398.00 | $391903.00 | $405177.00 | $425094.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $28714.00 | $26844.00 | $26844.00 | $26844.00 |
| Depreciation & Amortization | $1016.00 | $1017.00 | $1245.00 | $1358.00 |
| EBITDA | -$784382.00 | -$275801.00 | -$403932.00 | -$423736.00 |
| EBITDA Ratio | ||||
| Operating Income | -$785398.00 | -$391903.00 | -$405177.00 | -$425090.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$28714.00 | $88241.00 | -$26844.00 | -$26844.00 |
| Income Before Tax | -$814112.00 | -$303662.00 | -$432021.00 | -$451938.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $2.00 |
| Net Income | -$814112.00 | -$303662.00 | -$432021.00 | -$451938.00 |
| Net Income Ratio | ||||
| EPS | -$0.003 | -$0.001 | -$0.002 | -$0.002 |
| Diluted EPS | -$0.003 | -$0.001 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $252.41M | $248.61M | $247.72M | $245.75M |
| Weighted Avg Shares Outstanding (Diluted) | $252.41M | $248.61M | $247.72M | $245.75M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan